Janssen Search
Search results
Biomarkers in Oncology
Biomarkers We are pursuing the era of personalized medicine through biomarkers. The Importance of Biomarkers Biomarkers are an increasingly important component of our drug development activities, and they are used in multiple ways. We see enormous ...
Mobile Health Monitoring – myhealthapps.net
MYHEALTHAPPS.NET for Mobile Health Monitoring Janssen supported the launch of an international healthcare website called MYHEALTHAPPS.net. This website was developed to help patients and the public in finding relevant healthcare apps for smartphones that ...
Cardiovascular, Metabolism & Retina
Cardiovascular & Metabolism Cardiovascular & Metabolism Micro Pancreas Pancreas Cardiovascular, Metabolism & Retina Discovering Underlying Mechanisms Research & Development: Accelerating the Molecule Commercialization of Cardiovascular ...
Discovering Neuroscience Innovation
Discovery “Our goal is to drive the types of discoveries that will ultimately improve the prevention, diagnosis, and treatment of neuropsychiatric, neurological, and neurodegenerative diseases for generations to come.” Simon Lovestone Global Head of ...
The Patients Are Waiting – Paul Janssen
We are driven by our belief that patients are waiting and there is no time to waste. Dr. Paul Janssen at the University of Ghent, Belgium, laboratories in the early 1950s. There he obtained his Ph.D. in Medicine in 1951 and his Ph.D. in Pharmacology in ...
Steve Wooding, M.D.
STEVE WOODING, M.D. HEAD, GLOBAL COMMERCIAL STRATEGY ORGANIZATION Steve Wooding, M. D., is Head, Global Commercial Strategy Organization (GCSO) and Market Access Organization, a position he assumed in June 2015. He is a member of the Pharmaceuticals Group ...
Grant to Harvard Medical School
New Grant to Harvard Medical School to Combat Drug-Resistant Tuberculosis As part of its ongoing commitment to global public health, Janssen entered into a novel collaboration with Harvard Medical School in Cambridge, Massachusetts, to address critical ...
Neuroscience
"With neuroscience as part of Janssen's origin story, we are focused on brain health, actively searching for solutions for all the people living with disorders of the nervous system." Bill Martin, Ph.D. GLOBAL THERAPEUTIC AREA HEAD The ...
About Our Immunology Innovations
Redefining Treatment by Pioneering Pathway Science Retrovirus At Janssen Immunology, our vision is to restore health for the millions of people living with immune disease. Our approach to achieving this aspirational vision is systematic and evidence ...
Eric George, Ph.D.
As the Presbyopia/Cataracts Venture Leader of the Disease Interception Accelerator (DIA), Eric George leads the team’s efforts in exploring solutions aimed at stopping the progression of presbyopia and cataracts. Prior to joining the DIA, Eric worked for ...